Anti-interleukin-5/anti-interleukin-5 receptor α treatment improves self-reported work productivity in patients with severe eosinophilic asthma: a prospective cohort trial
Background Severe asthma affects the working life of millions of people worldwide. Interleukin (IL)-5/anti-interleukin-5 receptor α (IL-5Rα) antibodies are highly effective in reducing symptoms in patients with severe eosinophilic asthma. We analysed effects of anti-IL-5/anti-IL-5Rα treatment on sel...
Saved in:
Main Authors: | Lina Brinkmann, Jan Fuge, Tobias Welte, Hendrik Suhling, Nora Drick |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2024-11-01
|
Series: | ERJ Open Research |
Online Access: | http://openres.ersjournals.com/content/10/6/00374-2024.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interleukin-5 Potentiates Sulfidopeptide Leukotriene Production by Human Eosinophils
by: A. J. M. Van Oosterhout, et al.
Published: (1994-01-01) -
Role of interleukin-4 receptor α polymorphism in patients with asthma and its correlation with asthma severity
by: Nidhi Girdhar, et al.
Published: (2025-01-01) -
Anti-Interleukin-6 Receptor Antibody Therapy-Induced Retinopathy in a Patient with Rheumatoid Arthritis
by: Asumi Tada, et al.
Published: (2012-01-01) -
Use of Anti-Interleukin-6 Receptor Monoclonal Antibody in Drug-Induced Acute Respiratory Distress Syndrome
by: Alessandra Petrillo, et al.
Published: (2020-01-01) -
Interleukin-2/Anti-Interleukin-2 Immune Complex Expands Regulatory T Cells and Reduces Angiotensin II-Induced Aortic Stiffening
by: Beenish Majeed, et al.
Published: (2014-01-01)